Patents by Inventor Kevin Van Bladel

Kevin Van Bladel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11903834
    Abstract: According to one embodiment, a heart anchor tensioning device includes a main body and an elongate shaft. A tension member or tether may be inserted through a lumen of the elongate shaft to allow the shaft to be advanced over the tension member and within a body while the main body is positioned outside of the body. The device also includes an anchor coupling mechanism that is configured to engage a heart anchor and move the heart anchor into engagement with a first wall of the heart. The anchor coupling mechanism is able to lock the heart anchor to inhibit proximal movement of the heart anchor along the tension member. The device further includes a tension indicating mechanism that provides an indication of a force being applied to the heart anchor by the device.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: February 20, 2024
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon Annest, Ernest Heflin, Gilbert Mata, Jr., Lawrence Crainich, Brian LaRose
  • Patent number: 11744615
    Abstract: A method for performing a therapeutic intervention in a pericardial space of a heart includes delivering a catheter into a right atrium of the heart and steering the catheter so that a distal end of the catheter is positioned adjacent an access site in the right atrium. The distal end of the catheter is anchored in a heart wall of the right atrium adjacent the access site and the heart wall is inverted to separate an exterior surface of the inverted heart wall from contact with parietal pericardial tissue. The inverted heart wall is penetrated to provide access to the pericardial space around the heart. A device is delivered through the penetrating in the inverted heart wall to perform the therapeutic intervention in the pericardial space.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: September 5, 2023
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon S. Annest, Michael S. Dana
  • Patent number: 11559212
    Abstract: According to one embodiment, a tissue penetrating device includes an elongate shaft having a proximal end, a distal end, and a lumen extending there between. A first needle is disposed within the lumen of the elongate shaft and is extendable therefrom between a first configuration and a second configuration. In the first configuration, the first needle is disposed within the elongate shaft's lumen and is substantially aligned with an axis of the lumen. In the second configuration, the first needle extends distally of the elongate shaft's distal end and bends away from the lumen's axis. A second needle is disposed within a lumen of the first needle and is extendable therefrom when the first needle is positioned in the first configuration and when the first needle is positioned in the second configuration. The second needle may be extended from the first needle to penetrate tissue of a patient.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: January 24, 2023
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Meir Moshe, Lon Annest
  • Patent number: 11540822
    Abstract: A heart tissue gripping device may include a body portion, an elongate shaft, and a tissue gripping member that is attached to the distal end of the elongate shaft. The tissue gripping member being may be positioned adjacent a heart surface by insertion through an incision in the body. The tissue gripping member may releasably attach to tissue of the heart surface to facilitate a surgical instrument in performing one or more procedures. A coupling of the tissue gripping member may releasably attach the surgical device to the tissue gripping member to allow the device to access the tissue of the heart surface.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: January 3, 2023
    Assignee: BioVentrix, Inc.
    Inventors: Meir Moshe, Lon S. Annest, Kevin Van Bladel
  • Patent number: 11529234
    Abstract: According to one embodiment, a protective device for use in congestive heart failure treatments, and other treatments, includes a control mechanism, an elongate shaft, and a protective plate. The control mechanism is coupled with a proximal end of the elongate shaft and the protective plate is pivotably coupled with a distal end of the elongate shaft. The elongate shaft enables the protective plate to be inserted within a body and navigated distally of a heart wall. The protective plate has a relatively wide and thin body portion and is pivotable relative to the elongate shaft by operation of the control mechanism. Pivoting and/or navigating of the protective plate within the body allows the protective plate to be positioned adjacent the heart wall to shield body organs or tissue surrounding the heart wall from being damaged by surgical instruments inserted through the heart wall.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: December 20, 2022
    Assignee: BIOVENTRIX, INC.
    Inventors: Kevin Van Bladel, Aaron Weiss, Lon Annest, Gilbert Mata, Jr.
  • Patent number: 11478353
    Abstract: A system for treating a heart includes a catheter that is advanceable into a chamber of the heart and that is repositionable within the chamber between a septal wall and an external wall to enable penetration of the septal and external walls via a needle that is disposed within a lumen of the catheter. A first guidewire is deliverable through the penetration of the septal wall so that a distal end of the first guidewire is disposed within another chamber of the heart. A second guidewire is deliverable through the penetration of the external wall so that a distal end of the second guidewire is disposed externally of the external wall. The first guidewire is connectable to the second guidewire to join or form a path within the chamber that extends between the septal wall and the external wall.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: October 25, 2022
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Serjan Nikolic, Lon Annest, Rovil Arcia
  • Publication number: 20220087715
    Abstract: A method for performing a therapeutic intervention in a pericardial space of a heart includes delivering a catheter into a right atrium of the heart and steering the catheter so that a distal end of the catheter is positioned adjacent an access site in the right atrium. The distal end of the catheter is anchored in a heart wall of the right atrium adjacent the access site and the heart wall is inverted to separate an exterior surface of the inverted heart wall from contact with parietal pericardial tissue. The inverted heart wall is penetrated to provide access to the pericardial space around the heart. A device is delivered through the penetrating in the inverted heart wall to perform the therapeutic intervention in the pericardial space.
    Type: Application
    Filed: September 24, 2020
    Publication date: March 24, 2022
    Inventors: Kevin Van Bladel, Lon S. Annest, Michael S. Dana
  • Publication number: 20220000622
    Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.
    Type: Application
    Filed: June 17, 2021
    Publication date: January 6, 2022
    Applicant: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
  • Patent number: 11185414
    Abstract: A heart implant alignment and delivery device includes an elongate body having an opening that is disposed near a distal end of the elongate body. The opening is configured so that a heart implant is positionable within the opening with the heart implant exposed to a surrounding environment and so that the heart implant is substantially aligned with the distal end of the elongate body. The device also includes an implant reposition member, such as a cable, that is releasably coupleable with the heart implant and that is operationally coupled with the elongate body so that a first operation of the implant reposition member causes the heart implant to be retractably deployed from the opening of the elongate body. The first operation of the implant reposition member may be effected via a handle mechanism that is attached to a proximal end of the elongate body.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: November 30, 2021
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Meir Moshe, Michael S. Dana
  • Patent number: 11051941
    Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue in a minimally invasive manner, often for treatment of congestive heart failure. In one embodiment, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface of the heart. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a delivery catheter. Delivering the anchor over the guidewire may provide improved control in the delivery and placement of the anchor within the right ventricle.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: July 6, 2021
    Assignee: BioVentrix, Inc.
    Inventors: Lon Annest, Murray Sheldon, Kevin Van Bladel, Ernie Heflin, William Butler, Andrew Wechsler, John Bower, Rovil Arcia
  • Patent number: 11051942
    Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: July 6, 2021
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
  • Publication number: 20200289268
    Abstract: According to one embodiment, a heart anchor tensioning device includes a main body and an elongate shaft. A tension member or tether may be inserted through a lumen of the elongate shaft to allow the shaft to be advanced over the tension member and within a body while the main body is positioned outside of the body. The device also includes an anchor coupling mechanism that is configured to engage a heart anchor and move the heart anchor into engagement with a first wall of the heart. The anchor coupling mechanism is able to lock the heart anchor to inhibit proximal movement of the heart anchor along the tension member. The device further includes a tension indicating mechanism that provides an indication of a force being applied to the heart anchor by the device.
    Type: Application
    Filed: January 16, 2020
    Publication date: September 17, 2020
    Applicant: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon S. Annest, Ernest Heflin, Gilbert Mata, JR., Lawrence Crainich, Brian LaRose
  • Publication number: 20200205981
    Abstract: According to one embodiment, a protective device for use in congestive heart failure treatments, and other treatments, includes a control mechanism, an elongate shaft, and a protective plate. The control mechanism is coupled with a proximal end of the elongate shaft and the protective plate is pivotably coupled with a distal end of the elongate shaft. The elongate shaft enables the protective plate to be inserted within a body and navigated distally of a heart wall. The protective plate has a relatively wide and thin body portion and is pivotable relative to the elongate shaft by operation of the control mechanism. Pivoting and/or navigating of the protective plate within the body allows the protective plate to be positioned adjacent the heart wall to shield body organs or tissue surrounding the heart wall from being damaged by surgical instruments inserted through the heart wall.
    Type: Application
    Filed: March 10, 2020
    Publication date: July 2, 2020
    Applicant: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Aaron Weiss, Lon Annest, Gilbert Mata, JR.
  • Publication number: 20200163664
    Abstract: A heart tissue gripping device may include a body portion, an elongate shaft, and a tissue gripping member that is attached to the distal end of the elongate shaft. The tissue gripping member being may be positioned adjacent a heart surface by insertion through an incision in the body. The tissue gripping member may releasably attach to tissue of the heart surface to facilitate a surgical instrument in performing one or more procedures. A coupling of the tissue gripping member may releasably attach the surgical device to the tissue gripping member to allow the device to access the tissue of the heart surface.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 28, 2020
    Applicant: BioVentrix, Inc.
    Inventors: Meir Moshe, Lon S. Annest, Kevin Van Bladel
  • Patent number: 10617524
    Abstract: According to one embodiment, a protective device for use in congestive heart failure treatments, and other treatments, includes a control mechanism, an elongate shaft, and a protective plate. The control mechanism is coupled with a proximal end of the elongate shaft and the protective plate is pivotably coupled with a distal end of the elongate shaft. The elongate shaft enables the protective plate to be inserted within a body and navigated distally of a heart wall. The protective plate has a relatively wide and thin body portion and is pivotable relative to the elongate shaft by operation of the control mechanism. Pivoting and/or navigating of the protective plate within the body allows the protective plate to be positioned adjacent the heart wall to shield body organs or tissue surrounding the heart wall from being damaged by surgical instruments inserted through the heart wall.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: April 14, 2020
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Aaron Weiss, Lon Annest, Gilbert Mata, Jr.
  • Patent number: 10588613
    Abstract: A heart tissue gripping device may include a body portion, an elongate shaft, and a tissue gripping member that is attached to the distal end of the elongate shaft. The tissue gripping member being may be positioned adjacent a heart surface by insertion through an incision in the body. The tissue gripping member may releasably attach to tissue of the heart surface to facilitate a surgical instrument in performing one or more procedures. A coupling of the tissue gripping member may releasably attach the surgical device to the tissue gripping member to allow the device to access the tissue of the heart surface.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: March 17, 2020
    Assignee: BioVentrix, Inc.
    Inventors: Meir Moshe, Lon Annest, Kevin Van Bladel
  • Patent number: 10575953
    Abstract: According to one embodiment, a heart anchor tensioning device includes a main body and an elongate shaft. A tension member or tether may be inserted through a lumen of the elongate shaft to allow the shaft to be advanced over the tension member and within a body while the main body is positioned outside of the body. The device also includes an anchor coupling mechanism that is configured to engage a heart anchor and move the heart anchor into engagement with a first wall of the heart. The anchor coupling mechanism is able to lock the heart anchor to inhibit proximal movement of the heart anchor along the tension member. The device further includes a tension indicating mechanism that provides an indication of a force being applied to the heart anchor by the device.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: March 3, 2020
    Assignee: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon Annest, Ernest Heflin, Gilbert Mata, Lawrence Crainich, Brian LaRose
  • Publication number: 20190336012
    Abstract: According to one embodiment, a tissue penetrating device includes an elongate shaft having a proximal end, a distal end, and a lumen extending there between. A first needle is disposed within the lumen of the elongate shaft and is extendable therefrom between a first configuration and a second configuration. In the first configuration, the first needle is disposed within the elongate shaft's lumen and is substantially aligned with an axis of the lumen. In the second configuration, the first needle extends distally of the elongate shaft's distal end and bends away from the lumen's axis. A second needle is disposed within a lumen of the first needle and is extendable therefrom when the first needle is positioned in the first configuration and when the first needle is positioned in the second configuration. The second needle may be extended from the first needle to penetrate tissue of a patient.
    Type: Application
    Filed: May 15, 2019
    Publication date: November 7, 2019
    Applicant: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Meir Moshe, Lon Annest
  • Publication number: 20190307564
    Abstract: A heart implant alignment and delivery device includes an elongate body having an opening that is disposed near a distal end of the elongate body. The opening is configured so that a heart implant is positionable within the opening with the heart implant exposed to a surrounding environment and so that the heart implant is substantially aligned with the distal end of the elongate body. The device also includes an implant reposition member, such as a cable, that is releasably coupleable with the heart implant and that is operationally coupled with the elongate body so that a first operation of the implant reposition member causes the heart implant to be retractably deployed from the opening of the elongate body. The first operation of the implant reposition member may be effected via a handle mechanism that is attached to a proximal end of the elongate body.
    Type: Application
    Filed: February 13, 2019
    Publication date: October 10, 2019
    Applicant: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Meir Moshe, Michael S. Dana
  • Publication number: 20190274833
    Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.
    Type: Application
    Filed: January 8, 2019
    Publication date: September 12, 2019
    Applicant: BioVentrix, Inc.
    Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower